This site is intended for health professionals only
Wednesday 29 March 2017
Share |

Latest News

NICE recommends Zinbryta for treatment of relapsing-remitting multiple sclerosis

Thursday 16th March 2017

The National Institute for Health and Care Excellence (NICE) has recommended ZINBRYTA® (daclizumab) for the treatment of adult patients living with relapsing-remitting multiple sclerosis (RRMS).

The Final Appraisal Determination, published today, recommends that daclizumab be considered as a treatment option for patients with active, relapsing-remitting multiple sclerosis who have failed to respond...

Tue, 14 Mar 2017
Positive scientific opinion under the Early Access to Medicines Scheme (EAMS) recognises the burden of severe atopic dermatitis and significant unmet patient needs
Thu, 9 Mar 2017
The position paper outlines some of the considerations that are relevent when making a decision to switch
Thu, 9 Mar 2017
Royal Phillips and LabPON announced plans to create a digital database of massive aggregated sets of annotated pathology using Phillips Intelisite Pathology Solution.
Thu, 2 Mar 2017
Long-term safety and low annual bleed rate maintained in longest study of an extended half-life therapy for haemophilia B
Tue, 28 Feb 2017
Philips Minicare cTnI point-of-care blood test used for the first time in a rapid diagnosis protocol to improve patient experience and free up hospital resources
Tue, 28 Feb 2017
Results from new global survey for IPF patients show that opportunities still exist to improve dialogue between healthcare professionals and their patients.
Mon, 27 Feb 2017
Janssen’s first-in-class CD38-directed monoclonal antibody now recommended for approval earlier in the treatment pathway in combination with two standard of care regimens